Sun Vs Ranbaxy: Stock Performance Since 2008
  • Prabha Hedge
  • Apr 07 2014

April 7: Sun Pharmaceutical, India's largest drugmaker by market value, has agreed to buy Ranbaxy in a $4 billion all-stock deal. Priyank Lakhia gets you a detailed report on how both the stocks have performed since 2008.